INVEST 2024
Join us to hear from innovative investors and entrepreneurs offering novel approaches to solve some of healthcare’s greatest challenges.
Related Articles
Q1 Was Pretty Good For Hospital Finance — But It’s Unclear If It Will Stay That Way – MedCity News
Hospitals’ operating margins and patient volumes dropped slightly in March. While hospitals were doing relatively well financially during the first quarter of the year, this…
Navigating the Transition to Value-Based Care: Addressing Fears and Embracing Risk in ACO REACH – MedCity News
Offering blended options, individual risk pools, and net neutral capitation payments providers can embark on their journey toward value-based care at a pace aligned with…
Amgen Puts Its Weight Behind Obesity Drug With Potential Edge Over Lilly, Novo Nordisk Meds – MedCity News
Amgen is confident its injectable obesity drug would have a differentiated profile compared to medications now on the market from Novo Nordisk and Eli Lilly…
Kaiser Permanente Is Deploying Innovaccer’s Value-Based Care AI Across Washington – MedCity News
Kaiser Permanente is deploying Innovaccer’s healthcare AI platform and population health management tools to support better value-based care — starting with its Washington market and…
Debunked Episode 4
In this episode we discuss abortion and the Arizona’s House and Senate voted to repeal the 1864 law that nearly banned all abortions after this…
Debunked Episode 4
In this episode we discuss abortion and the Arizona’s House and Senate voted to repeal the 1864 law that nearly banned all abortions after this…
How Companies Can Improve Their Learning and Development Strategy and Why it is Essential in the Life Sciences Space – MedCity News
Some specific topics that should be prioritized at all levels
23andMe: What If … – MedCity News
A much diminished 23andMe exists today, a far cry from the phenomenon that it was in the world consumer DNA testing. Could things have unfolded…
INVEST 2024
Join us to hear from innovative investors and entrepreneurs offering novel approaches to solve some of healthcare’s greatest challenges.
Novartis Extends Its Reach in Radiopharmaceuticals With $1B Mariana Oncology Acquisition – MedCity News
Mariana Oncology brings Novartis a lead radiopharmaceutical program in development for small cell lung cancer. The deal is the latest in a string of big…